scholarly journals Chronic Hepatitis B Infection Amongst PrEP Users Enrolled in a Population-Based Program in British Columbia, Canada

Author(s):  
Kyle Thompson ◽  
Gabriel Blank ◽  
Junine Toy ◽  
David M Moore ◽  
Nathan Lachowsky ◽  
...  

Abstract Initiation of HIV Pre-Exposure Prophylaxis (PrEP) medications will also treat hepatitis B infection (HBV). The prevalence of chronic HBV was 0.86% (n=41/4,760) among enrollees in a provincial PrEP program in British Columbia, Canada. Overall, 46.3% lacked follow-up HBV DNA monitoring, underscoring the need for HBV-related education for PrEP prescribers.

2015 ◽  
Vol 148 (4) ◽  
pp. S-501
Author(s):  
Hossein Poustchi ◽  
Aezam Katoonizadeh ◽  
Mohammad Reza Ostovaneh ◽  
Shirin Moossavi ◽  
maryam sharafkhah ◽  
...  

2011 ◽  
Vol 140 (5) ◽  
pp. S-896 ◽  
Author(s):  
Phunchai Charatcharoenwitthaya ◽  
Pochamana Phisalprapa ◽  
Pimpattana Rungkaew ◽  
Sorrayut Kajornvuthidej ◽  
Wimolrak Bandidniyamanon ◽  
...  

Complexity ◽  
2020 ◽  
Vol 2020 ◽  
pp. 1-19
Author(s):  
Bo Wu ◽  
Jianwen Jia

In this paper, a stochastic delayed model is constructed to describe chronic hepatitis B infection with HBV DNA-containing capsids. At first, the existence and uniqueness of the global positive solution are obtained. Secondly, the sufficient conditions are derived that the solution of the stochastic system fluctuates around the disease-free equilibrium E0 and the endemic equilibrium E∗. In the end, some numerical simulations are implemented to support our analytical results.


Sign in / Sign up

Export Citation Format

Share Document